Kristian Helin
Professor Kristian Helin is the chief executive of the Institute of Cancer Research in London and a leading figure in cancer research. He has recently been in the news for discussing the promising results of a clinical trial that showed immunotherapy, specifically pembrolizumab, can double the time patients with head and neck cancer remain free from evidence of the disease. His insights highlight the transformative potential of immunotherapy in cancer treatment.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Prof Kristian Helin, the chief executive of the Institute of Cancer Research, said: 'Immunotherapy continues to deliver ...'
8